Mizuho analyst Vikram Malhotra maintains Highwoods Props (NYSE:HIW) with a Neutral and lowers the price target from $46 to $37.
Clover Health Investments Q4 Sales $898.79M Beat $785.38M Estimate
Clover Health Investments (NASDAQ:CLOV) reported quarterly sales of $898.79 million which beat the analyst consensus estimate of $785.38 million by 14.44 percent. This is a 108.04 percent increase over sales of $432.04
